Skip to content

Contraceptive Choice Center

The Center for Contraceptive Excellence: an Innovative Health Services Delivery and Payment Model

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02633631
Acronym
C3
Enrollment
2664
Registered
2015-12-17
Start date
2015-01-31
Completion date
2020-04-30
Last updated
2021-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception, Family Planning, Unintended Pregnancy

Brief summary

The Contraceptive Choice Center will use an innovative-model of contraceptive care which was developed as a part of the Contraceptive CHOICE Project (CHOICE). This delivery model will deliver high-quality family planning services for women and reduce unintended pregnancies and births. This intervention will result in improved health for women, improved health care, and reduced costs to Medicaid. The Center will provide care to women ages 14-45 years of age.

Detailed description

The Center will provide high-quality contraceptive care using the innovative model of the Contraceptive CHOICE Project. Specifically, the model will provide the following components: 1) Structured, evidence-based contraceptive counseling; 2) education of providers about long-acting reversible contraceptive (LARC) methods and evidence-based guidelines for contraceptive provision; 3) removal of patient barriers to family planning services; and 4) post-visit contraceptive support. The model addresses the barriers to contraceptive uptake.

Interventions

None listed

Sponsors

Centers for Medicare and Medicaid Services
CollaboratorFED
Washington University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Childbearing-age seeking family planning services * Negative pregnancy test * Willing and able to undergo informed consent

Exclusion criteria

* Current participation in a research study that would interfere with the conduct of this study * Currently pregnant

Design outcomes

Primary

MeasureTime frameDescription
Rate of unintended pregnancy24 monthsReduce unintended pregnancy by 10% - # of pregnancies that are unintended per 1000 reproductive-age women (14-45 years)

Secondary

MeasureTime frameDescription
Rate of unintended births24 monthsReduce unintended births and associated costs by 15% - # of births that are unintended per 1000 reproductive age women

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026